Tag: spinal cord stimulation

Nevro announces clinical data reinforcing significant and durable benefits of 10kHz...

Nevro Corporation has announced the results from data presentations at the 25th North American Neuromodulation Society (NANS) annual meeting (13–15 January 2022; Orlando, USA) supporting...

FDA grants StimuLux system breakthrough device designation

Wavegate Corporation has announced that the US Food and Drug Administration (FDA) has granted breakthrough device designation for its StimuLux optical reflectometry system for...

DTM spinal cord stimulation endurance therapy associated with meaningful pain relief...

Differential Target Multiplexed (DTM) spinal cord stimulation (SCS) endurance therapy provides meaningful pain relief according to three-month data from the DTM-LE trial—the findings of...
spinal cord stimulation patient access

Current gaps and barriers in patient access to spinal cord stimulation

Maricela Schnur (St Luke’s Hospital, Duluth, USA) highlights a handful of socioeconomic disparities, racial differences, and psychological and psychiatric factors, that currently present difficulties...

Proclaim XR spinal cord stimulation system gets expanded MRI compatibility boost

Abbott has announced that the US Food and Drug Administration (FDA) has approved new expanded magnetic resonance imaging (MRI) compatibility for its Proclaim XR spinal cord...

Passive recharge burst spinal cord stimulation provides sustainable improvements in pain...

Passive recharge burst spinal cord stimulation (B-SCS) can alleviate pain intensity, psychological distress, and improve physical function and health-related quality of life out to two years,...
scs diabetic neuropathy

High-frequency SCS takes the stage to relieve chronic pain from diabetic...

Following the recent approval of the Senza system (Nevro) by the US Food and Drug Administration (FDA), Erika A Petersen (Little Rock, USA) discusses the...

NeoSpine first to offer spinal cord stimulation for treatment of painful...

NeoSpine is now offering spinal cord stimulation (SCS) procedures for the treatment of painful diabetic neuropathy (PDN) via its HFX system—a newly approved nondrug treatment...

Boston Scientific launches FAST—a new therapy for spinal cord stimulation

Boston Scientific has announced the European launch of FAST—a new fast-acting sub-perception therapy that the company says is clinically proven to demonstrate significant and...
nevro senza

Nevro announces FDA approval of high-frequency SCS therapy for painful diabetic...

Nevro has announced receipt of US Food and Drug Administration (FDA) approval for its Senza system to treat chronic pain associated with painful diabetic...

New ultra-thin Inflatable spinal implants could help treat severe pain

A team of engineers and clinicians at the University of Cambridge (Cambridge, UK) have developed an ultra-thin, inflatable spinal device that can be used...

WaveWriter Alpha Spinal Cord Stimulator System wins Best Overall Medical Device...

The WaveWriter Alpha Spinal Cord Stimulator (SCS) System (Boston Scientific) has been named Best Overall Medical Device Solution at the fifth annual MedTech Breakthrough...

Medtronic launches spinal cord stimulation therapy mobile app

Medtronic has announced the launch of CareGuidePro, a new mobile application and web portal that serves as a virtual guide for patients throughout their...

Nevro receives US FDA approval for Senza Omnia spinal cord stimulation...

  Nevro has received approval from the US Food and Drug Administration (FDA) for the Senza Omnia spinal cord stimulation system to treat chronic pain....
Senza

Nevro receives TGA approval for Senza II spinal cord stimulation system...

The Therapeutic Goods Administration (TGA) has granted approval to Nevro for its next-generation Senza II spinal cord stimulation system delivering the company’s proprietary HF10...

Immediate restoration of voluntary movement with epidural spinal cord stimulation in...

In a small cohort of patients, spinal cord stimulation has been shown to restore volitional movement in select patients with paraplegia, after intensive therapy....
Metronic Intellis

Non-opioid alternative for chronic pain approved in Europe

A Conformité Européene (CE) Mark has been received by Medtronic for its neurostimulation platform Intellis for spinal cord stimulation (SCS) and peripheral nerve stimulation...
Profile: Todd Wetzel

Todd Wetzel

As his term as NASS president comes to a close, Spinal News International caught up with Todd Wetzel to discuss his career to date,...

Flexible battery could revolutionise implanted devices

Experts at Queen’s University Belfast, Belfast, UK, have designed a flexible battery that could provide an alternative to the rigid batteries that usually power...

CE mark approval for Stimwave’s world-first fully percutaneous spinal cord stimulator...

CE mark approval has been granted for the world’s first percutaneous injectable anchor system, SandShark. The Stimwave system is used to fixate the company’s...

NASS’ allograft and spinal cord stimulation coverage recommendations open for public...

The president of the North American Spine Society (NASS), F Todd Wetzel (Philadelphia, USA), has announced the opening of the society’s 30-day public comment...

Man moves paralysed legs using spinal cord stimulation

Mayo Clinic (Rochester, USA) researchers have used electrical stimulation on the spinal cord and intense physical therapy to help a man intentionally move his...

Spinal cord stimulation reduces or stabilises opioid use among chronic pain...

New research has found spinal cord stimulation therapy can reduce or stabilise the use of opioids in patients battling chronic pain. Researchers examined opioid...

Most patients with chronic truck or limb pain experience “substantial” pain...

Twenty-four month data from a postmarket, clinical registry have found that most patients suffering from chronic pain of the trunk and/or limbs reported “substantial”...